CHEBI:228259 - AZ505

Main ChEBI Ontology Automatic Xrefs Reactions Pathways Models
ChEBI Name AZ505
ChEBI ID CHEBI:228259
Definition A benzoxazine that is 2H-1,4-benzoxazin-3(4H)-one substituted by a hydroxy group at position 5 and a 2-{[2-(cyclohexyl{N-[2-(3,4-dichlorophenyl)ethyl]-β-alanyl}amino)ethyl]amino}ethyl group at position 8. It is a potent and selective inhibitor of SMYD2.
Stars This entity has been manually annotated by the ChEBI Team.
Submitter Jonathan Muyskens
Supplier Information
Download Molfile XML SDF
Formula C29H38Cl2N4O4
Net Charge 0
Average Mass 577.550
Monoisotopic Mass 576.22701
InChI InChI=1S/C29H38Cl2N4O4/c30-23-8-6-20(18-24(23)31)10-13-32-15-12-27(38)35(22-4-2-1-3-5-22)17-16-33-14-11-21-7-9-25(36)28-29(21)39-19-26(37)34-28/h6-9,18,22,32-33,36H,1-5,10-17,19H2,(H,34,37)
InChIKey LIBVHXXKHSODII-UHFFFAOYSA-N
SMILES OC1=C2NC(=O)COC2=C(CCNCCN(C2CCCCC2)C(=O)CCNCCC2=CC(Cl)=C(Cl)C=C2)C=C1
Roles Classification
Chemical Role(s): Bronsted base
A molecular entity capable of accepting a hydron from a donor (Bronsted acid).
(via organic amino compound )
Biological Role(s): EC 2.1.1.354 ([histone H3]-lysine(4) N-trimethyltransferase) inhibitor
An EC 2.1.1.* (methyltransferases) inhibitor that interferes with the action of [histone H3]-lysine4 N-trimethyltransferase (EC 2.1.1.354).
Application(s): antineoplastic agent
A substance that inhibits or prevents the proliferation of neoplasms.
View more via ChEBI Ontology
ChEBI Ontology
Outgoing AZ505 (CHEBI:228259) has role antineoplastic agent (CHEBI:35610)
AZ505 (CHEBI:228259) has role EC 2.1.1.354 ([histone H3]-lysine4 N-trimethyltransferase) inhibitor (CHEBI:228263)
AZ505 (CHEBI:228259) is a benzoxazine (CHEBI:46969)
AZ505 (CHEBI:228259) is a dichlorobenzene (CHEBI:23697)
AZ505 (CHEBI:228259) is a organic hydroxy compound (CHEBI:33822)
AZ505 (CHEBI:228259) is a secondary amino compound (CHEBI:50995)
AZ505 (CHEBI:228259) is a tertiary carboxamide (CHEBI:140326)
IUPAC Name
N-cyclohexyl-N3-[2-(3,4-dichlorophenyl)ethyl]-N-(2-{[2-(5-hydroxy-3-oxo-3,4-dihydro-2H-1,4-benzoxazin-8-yl)ethyl]amino}ethyl)-β-alaninamide
Synonyms Sources
AZ 505 ChEBI
AZ-505 ChEBI
N-cyclohexyl-3-[2-(3,4-dichlorophenyl)ethylamino]-N-[2-[2-(5-hydroxy-3-oxo-4H-1,4-benzoxazin-8-yl)ethylamino]ethyl]propanamide SUBMITTER
Registry Number Type Source
1035227-43-0 CAS Registry Number SUBMITTER
Citations Waiting for Citations Types Sources
21782458 PubMed citation Europe PMC
25834495 PubMed citation Europe PMC
28588028 PubMed citation Europe PMC
28604386 PubMed citation Europe PMC
29487338 PubMed citation Europe PMC
31754403 PubMed citation Europe PMC
32277055 PubMed citation Europe PMC
33935284 PubMed citation Europe PMC
34143514 PubMed citation Europe PMC
34510321 PubMed citation Europe PMC
34905676 PubMed citation Europe PMC
35455942 PubMed citation Europe PMC
35759739 PubMed citation Europe PMC
35939202 PubMed citation Europe PMC
36046818 PubMed citation Europe PMC
37036190 PubMed citation Europe PMC
37315132 PubMed citation Europe PMC
37524453 PubMed citation Europe PMC
Last Modified
01 December 2023